Family Resilience And Mind-body Enhancement (FRAME)
NCT07920380, Not applicable, Not yet recruiting, The University of Hong Kong
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Family Resilience And Mind-body Enhancement (FRAME) | ClinicalTrials.gov |
| NCT number | NCT07920380 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 114 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | The University of Hong Kong | ClinicalTrials.gov |
| Conditions | Autism | ClinicalTrials.gov |
| Interventions | Family Resilience And Mind-body Enhancement" (FRAME) | ClinicalTrials.gov |
| First posted | 2026-11-05 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Parenting stress | From baseline (T0) to the end of treatment at 6 weeks (T1) | Parenting stress will be measured using Parenting Stress Index - Short Form (PSI-4-SF) 4th edition. Total score ranges from 36 to 180, with higher scores indicating greater parenting distress. | ClinicalTrials.gov |
| Primary | Parenting stress | From baseline (T0) to the end of treatment at 18 weeks (T2) | Parenting stress will be measured using Parenting Stress Index - Short Form (PSI-4-SF) 4th edition. Total score ranges from 36 to 180, with higher scores indicating greater parenting distress. | ClinicalTrials.gov |
| Secondary | Parental distress | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using the Depression Anxiety Stress Scale-21 (DASS-21). Total score ranges from 0 to 63, with higher scores indicating greater distress. | ClinicalTrials.gov |
| Secondary | Parental Well-being | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using the World Health Organization Five Well-Being Index (WHO-5). The raw score ranges from 0 to 25. Higher scores indicate better well-being. | ClinicalTrials.gov |
| Secondary | Mindful parenting | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured by the 23-item validated Chinese version of Interpersonal Mindfulness in Parenting Scale (IM-P). The total score ranges from 23 to 115. Higher scores indicate more mindfulness in parenting | ClinicalTrials.gov |
| Secondary | Child emotional and behavioural and problems | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using both parent- and teacher-report Strengths and Difficulties Questionnaire (SDQ). The total difficulties score ranges from 0 to 40. Higher scores indicate greater emotional and behavioural and problems. | ClinicalTrials.gov |
| Secondary | Sibling emotional and behavioural problems (only for families with more than one child) | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using parent-report Strengths and Difficulties Questionnaire (SDQ). The total difficulties score ranges from 0 to 40. Higher scores indicate greater emotional and behavioural and problems. | ClinicalTrials.gov |
| Secondary | Parent-sibling relationship (only for families with more than one child) | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using the Parent-Child Dysfunctional Interaction subscale of the PSI-4-SF. The subscale score ranges from 12 to 60. Higher scores indicate greater dysfunctional interaction and poorer relationship. | ClinicalTrials.gov |
| Secondary | Parent-child relationship | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using the Parent-Child Dysfunctional Interaction subscale of the PSI-4-SF. The subscale score ranges from 12 to 60. Higher scores indicate greater dysfunctional interaction and poorer relationship. | ClinicalTrials.gov |
| Secondary | Marital satisfaction (only for married parents) | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using the Kansas Marital Satisfaction Scale (KMS). The total score ranges from 3 to 21, with higher scores indicating greater marital satisfaction. | ClinicalTrials.gov |
| Secondary | Family resilience | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using the 26-item validated Chinese version of Walsh Family Resilience Questionnaire (WFRQ). The total score ranges from 26 to 130. Higher scores indicate greater family resilience. | ClinicalTrials.gov |
| Secondary | Family functioning | Baseline (T0), 6 weeks (T1), 18 weeks (T2) | Measured using the 12-item General Functioning subscale of the McMaster Family Assessment Device (FAD). The total score ranges from 1 to 4, with scores calculated as the mean of the 12 items. Higher scores indicate worse family functioning. | ClinicalTrials.gov |
| Secondary | Intervention acceptability | Assessed at T1 (immediately post-intervention) | A 4-item self-reported program evaluation measured on a 10-point scale, assessing: (a) easiness of the program contents, (b) usefulness of the treatment, (c) overall satisfaction, and (d) likelihood to recommend the treatment to others. Total scores range from 1 to 10, with higher scores indicating greater acceptability. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)